Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
LOADING
|||
ROE: Strong Returns
Trending higher, above historical average, structural decline.
Left:
||||
Return on equity
Latest
-0.35%
↑ 99% above average
Average (9y)
-65.30%
Historical baseline
Range
High:27.79%
Low:-323.27%
CAGR
-45.7%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2025 | -0.35% | +99.9% |
| 2024 | -323.27% | -327.3% |
| 2023 | -75.65% | -71.2% |
| 2022 | -44.18% | -28.2% |
| 2021 | -34.45% | -88.2% |
| 2020 | -18.31% | -165.9% |
| 2019 | 27.79% | +148.9% |
| 2018 | -56.84% | -34.6% |
| 2017 | -42.22% | +50.6% |
| 2016 | -85.50% | - |